Retatrutide is an investigational peptide therap that targets three key metabolic hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
Brands with functional values that minimize or offset the drugs side effects stand to benefit if this occurs
5, [online] Available at: (accessed 7th april 2022)
Ela classificada como um triplo agonista , pois atua simultaneamente nos receptores de GLP-1, GIP e glucagon diferentemente da tirzepatida, que age apenas sobre GLP-1 e GIP, e da semaglutida e liraglutida, que atuam exclusivamente sobre GLP-1
BPC 157 stands for the body protection compound 157
GIP Receptor Distribution GIP receptors are found in your pancreas (beta cells and alpha cells), fat tissue (adipocytes), bone, brain (limited distribution compared to GLP-1), stomach, and intestines